Linc 2023 - Two big data of drug-eluting therapy (DET) in Japan: POPCORN and CAPSICUM
Join Yann Gouëffic as he provides a comprehensive overview of two Japanese registries showcased at the Linc 2023 Symposium in June.
The first registry, known as POPCORN, reveals its 2-year results, offering valuable insights into the real-life effectiveness of drug-coated balloons for the treatment of femoropopliteal disease.
In the same vein, the second registry, CAPSICUM, presents its 3-year outcomes, examining the contemporary real-life results of paclitaxel-eluting peripheral stents in addressing symptomatic lower limb ischemia associated with superficial femoral or proximal popliteal lesions.
Will these findings have a positive impact on interventional vascular medicine? Watch video and learn more.
Professor of Vascular Surgery
President of the association of the french university hospitals for clinical research
Conflicts of interest:
Research funding from Predisurge, Biotronik, WL Gore, GE Healthcare
Honoraria from Abbott, BD, Bentely, Biotronik, Boston Scientific, Cook, Eclevar Medtech, GE Healthcare, Ivascular, Medtronic, Penumbra, Sensome, Shockwave medical, WL Gore (consulting, medical advisory board, educational course, speaking)
